JPH0441457A - Production of eicosapentaenoic acid or its ester - Google Patents

Production of eicosapentaenoic acid or its ester

Info

Publication number
JPH0441457A
JPH0441457A JP2145617A JP14561790A JPH0441457A JP H0441457 A JPH0441457 A JP H0441457A JP 2145617 A JP2145617 A JP 2145617A JP 14561790 A JP14561790 A JP 14561790A JP H0441457 A JPH0441457 A JP H0441457A
Authority
JP
Japan
Prior art keywords
eicosapentaenoic acid
ester
column
distillation column
distillation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2145617A
Other languages
Japanese (ja)
Other versions
JP3040136B2 (en
Inventor
Kazuhiko Hata
和彦 秦
Hideo Noda
秀夫 野田
Masahiro Makuta
幕田 昌弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kansai Kagaku Kikai Seisaku KK
Nissui Corp
Original Assignee
Kansai Kagaku Kikai Seisaku KK
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansai Kagaku Kikai Seisaku KK, Nippon Suisan Kaisha Ltd filed Critical Kansai Kagaku Kikai Seisaku KK
Priority to JP2145617A priority Critical patent/JP3040136B2/en
Priority to CA002043615A priority patent/CA2043615C/en
Priority to DE69123880T priority patent/DE69123880T2/en
Priority to DK91305044.9T priority patent/DK0460917T3/en
Priority to AT91305044T priority patent/ATE147062T1/en
Priority to NO912144A priority patent/NO177699C/en
Priority to KR1019910009345A priority patent/KR100208701B1/en
Priority to EP91305044A priority patent/EP0460917B1/en
Priority to ES91305044T priority patent/ES2095909T3/en
Priority to AU78186/91A priority patent/AU641016B2/en
Publication of JPH0441457A publication Critical patent/JPH0441457A/en
Priority to GR970400347T priority patent/GR3022660T3/en
Priority to JP10354409A priority patent/JPH11236591A/en
Application granted granted Critical
Publication of JP3040136B2 publication Critical patent/JP3040136B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the subject compound by using >=3 distillation columns including a separately installed fractionating column for the initial distillate of fatty acids having low carbon number, distilling main fraction from a mixture containing eicosapentaenoic acid or its derivative by a specific method, converting the compound into a urea adduct and extracting the adduct. CONSTITUTION:The objective fatty acid or its ester mixture is produced from natural oil and fat containing eicosapentaenoic acid or its ester by using >=3 distillation columns 1-4 including a separately installed fractionating column for the initial distillate of fatty acids having low carbon number, refluxing the column bottom liquid of the fractionating column to the former-stage distillation column, continuously distilling in a vacuum of <=10 Torr and a column bottom temperature of <=210 deg.C to recover the main fraction D composed mainly of eicosapentaenoic acid or its ester, contacting the main fraction with a urea solution, extracting with a non-polar solvent and distilling out the solvent to obtain the subject compound having a concentration of >=85%. Preferably, the fractionating column for the main distillate and the fractionating column for the latter distillate are separately installed to perform continuous distillation operation.

Description

【発明の詳細な説明】 (産業上の利用分野) この発明は、高濃度エイコサペンタエン酸またはそのエ
ステルの製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a method for producing highly concentrated eicosapentaenoic acid or its ester.

さらに詳しくはこの発明は、血栓性疾患の治療および予
防のための処方剤として有用なエイコサペンタエン酸(
EPA)またはそのエステルの高濃度品の高効率生産を
可能とする新規な製造方法に関するものである。
More specifically, the present invention discloses eicosapentaenoic acid (
The present invention relates to a novel manufacturing method that enables highly efficient production of highly concentrated products of EPA) or its esters.

(従来の技術とその課題) 従来より、エイコサペンタエン酸(EPA)、およびそ
のエステル、アミド等は血栓生成の予防や血栓性疾患の
治療のための処方剤として有用なことがすでに知られて
いる。
(Prior art and its problems) It has been known that eicosapentaenoic acid (EPA) and its esters, amides, etc. are useful as prescription agents for preventing blood clot formation and treating thrombotic diseases. .

これらのエイコサペンタエン酸類は、天然油脂、特にサ
バ、イワシ、タラ等の水産物油脂中にそれ自体として、
あるいはそのグリセライド等の誘導体として含有されて
いることが知られており、これらの魚油等からエイコサ
ペンタエン酸類を取り出すための方法についての検討が
進められてきてもいる。
These eicosapentaenoic acids are present as such in natural oils and fats, especially marine oils and fats such as mackerel, sardines, and cod.
It is also known that eicosapentaenoic acids are contained in their derivatives such as glycerides, and studies are underway on methods for extracting eicosapentaenoic acids from these fish oils.

しかしながら、これらの魚油等からなる天然油脂中には
、炭素数20の不飽和脂肪酸であるエイコサペンタエン
酸以外の、炭素数19以下および21以上等の他の夾雑
する脂肪酸が圧倒的に多く含まれており、エイコサペン
タエン酸類のみを選択的に高濃度(高純度)品として効
率的に取出すことは困難を極めている。
However, these natural oils and fats such as fish oil contain an overwhelmingly large amount of other contaminating fatty acids, such as those with 19 or less carbon atoms and 21 or more carbon atoms, in addition to eicosapentaenoic acid, which is an unsaturated fatty acid with 20 carbon atoms. Therefore, it is extremely difficult to selectively extract only eicosapentaenoic acids as a high-concentration (high-purity) product.

たとえば、天然油脂からのエイコサペンタエン酸類の製
造方法として、天然油脂からの脂肪酸混合物をエステル
化し、これを減圧下に精密分留し、次いで、得られた留
分を尿素付加法によって精製する方法がこれまでに提案
されている(特開昭57−149400 ) 。
For example, as a method for producing eicosapentaenoic acids from natural oils and fats, there is a method in which a fatty acid mixture from natural oils and fats is esterified, this is precisely fractionated under reduced pressure, and then the obtained fraction is purified by a urea addition method. This has been proposed so far (Japanese Unexamined Patent Publication No. 57-149400).

10圓HQ、さらに好ましくは0.1〜0.01m+H
(lの減圧下にリング充填の1塔の精留塔において精密
分留し、さらに尿素付加法によって精製するこの方法に
よって、80%濃度程度のエイコサペンタエン酸エステ
ルが得られている。しかしながら、この方法によっても
、精留によって得られるC2゜留分中エイコサペンタエ
ン酸エステルはわずか30%程度にしかすぎず、しかも
尿素付別体処理や、さらにその後の減圧蒸留によっても
、高収率でその濃度を85%以上にまで向上させること
は極めて困難である。また、蒸留後に大量、かつ、多数
回の尿素処理が実際上必要となることから、その生産効
率の向上はもとより、生産コスト低減には大きな制約が
あり、プロセスの実用化には大きな問題があった。
10mm HQ, more preferably 0.1~0.01m+H
By this method, eicosapentaenoic acid ester with a concentration of about 80% has been obtained by precision fractionation in a rectification column packed with rings under a reduced pressure of Depending on the method, the eicosapentaenoic acid ester in the C2° fraction obtained by rectification is only about 30%, and even with urea treatment and subsequent vacuum distillation, its concentration can be reduced in high yield. It is extremely difficult to improve urea to 85% or more.Also, since it is actually necessary to treat a large amount of urea multiple times after distillation, it is difficult to improve production efficiency and reduce production costs. There were major limitations and there were major problems in putting the process into practical use.

この方法とほぼ同時に、2塔の蒸留塔を用いて、減圧条
件下に連続蒸留し、C2o留分として50%前後のエイ
コサペンタエン酸類を取得し、次いで尿素付加処理とカ
ラムクロマト精製する方法がこの発明の出願人によって
提案されてもいる(特開昭58−8037 ) 、この
方法によって蒸留精製や、全プロセスとしての効率は大
きく向上したものの、依然として85%以上の高濃度の
エイコサペンタエン酸またはそのエステルを実用プロセ
スとして製造することには成功していない、このため、
生産工程の合理化、生産効率の向上には限界があった。
At almost the same time as this method, two distillation columns are used to perform continuous distillation under reduced pressure conditions to obtain approximately 50% eicosapentaenoic acids as a CO fraction, followed by urea addition treatment and column chromatography purification. Although this method has been proposed by the applicant of the invention (Japanese Unexamined Patent Publication No. 58-8037), the efficiency of distillation purification and the overall process has been greatly improved, but it still has a high concentration of eicosapentaenoic acid or its equivalent of 85% or more. It has not been possible to successfully produce esters as a practical process; therefore,
There were limits to streamlining production processes and improving production efficiency.

医用処方剤として有用なエイコサペンタエン酸またはそ
のエステル等を臨床的に、あるいはさらに広範囲な疾患
領域への適用を目的とする研究のために使用していくた
めには、たとえばその濃度80%以上、さらには85%
以上のものを大量に高効率で生産することが強く望まれ
るが、以上の通りのこれまでの状況においては、このよ
うな要請に対応することはできなかった。
In order to use eicosapentaenoic acid or its ester, which is useful as a medical prescription agent, clinically or for research aimed at applying it to a wider range of disease areas, it is necessary to have a concentration of 80% or more, for example. Even 85%
Although it is strongly desired to produce the above items in large quantities and with high efficiency, it has not been possible to meet such a request under the current circumstances as described above.

この発明は、以上の通りの事情に鑑みてなされたもので
あり、従来の製造・精製方法の欠点を克服し、濃度85
%以上のエイコサペンタエン酸またはそのエステルを、
簡便に、かつ、高効率、低コストで取得することを可能
とする新しい方法を提供することを目的としている。
This invention was made in view of the above-mentioned circumstances, and it overcomes the drawbacks of conventional production and purification methods.
% or more of eicosapentaenoic acid or its ester,
The objective is to provide a new method that enables simple, highly efficient, and low cost acquisition.

(課題を解決するための手段) この発明は、上記の課題を解決するものとして、エイコ
サペンタエン酸またはその誘導体を含む天然油脂から得
られる脂肪酸またはそのエステルの混合物を、低炭素数
脂肪酸類初留分の精留塔を独立させた3塔以上の蒸留塔
において、この精留塔塔底液を前段蒸留塔に還流し、1
0 Torr以下の減圧および210℃以下の塔底温度
において連続蒸留し、得られたエイコサペンタエン酸ま
たはそのエステルを主成分として含有する主留分を尿素
メタノール溶液と接触させて尿素付加体を生成させ、非
極性溶媒を用いて抽出処理し、この非極性溶媒を留去し
て濃度85%以上のエイコサペンタエン酸またはそのエ
ステルを得ることを特徴とするエイコサペンタエン酸ま
たはそのエステルの製造方法を提供する。
(Means for Solving the Problems) The present invention solves the above problems by using a mixture of fatty acids or esters thereof obtained from natural fats and oils containing eicosapentaenoic acid or its derivatives as an initial distillate of low carbon number fatty acids. In a distillation column with three or more independent rectification columns, the bottom liquid of the rectification column is refluxed to the first distillation column, and
Continuous distillation is carried out at a reduced pressure of 0 Torr or less and a bottom temperature of 210° C. or less, and the obtained main fraction containing eicosapentaenoic acid or its ester as a main component is brought into contact with a urea methanol solution to produce a urea adduct. Provided is a method for producing eicosapentaenoic acid or its ester, which comprises performing an extraction treatment using a non-polar solvent and distilling off the non-polar solvent to obtain eicosapentaenoic acid or its ester with a concentration of 85% or more. .

また、この発明の方法は、前段蒸留塔の塔頂留分の凝縮
液を上記初留分精留塔に送ることや、エイコサペンタエ
ン酸またはそのエステルを主成分として含有する主留分
の精留塔と、後留(残留)分の精留塔とを各々独立して
設けて連続蒸留することを好ましい態様としてもいる。
The method of the present invention also includes sending the condensate of the top fraction of the first distillation column to the first distillation column, and rectifying the main fraction containing eicosapentaenoic acid or its ester as a main component. In a preferred embodiment, a column and a rectification column for the after-distillate (residual) fraction are provided independently to carry out continuous distillation.

またさらに、この発明は、各々の蒸留塔が独立した真空
系および凝縮系を有すること等を好ましい態様の一つと
してもいる。
Furthermore, one of the preferred embodiments of the present invention is that each distillation column has an independent vacuum system and condensation system.

エイコサペンタエン酸等の長鎖高度不飽和脂肪酸類は分
子内に二重結合が多いため、蒸留時の加熱によって劣化
や重合等の熱変性をおこしやすく、蒸留濃縮は著しく困
難である。
Long-chain highly unsaturated fatty acids such as eicosapentaenoic acid have many double bonds in their molecules, so they are susceptible to thermal denaturation such as deterioration and polymerization due to heating during distillation, making distillation and concentration extremely difficult.

また一方、エイコサペンタエン酸類を含有する天然油脂
は、エイコサペンタエン酸類以外に各種脂肪酸類を含み
、これらは沸点が近いため、蒸留塔の高さをかなり高く
し、還流量を多くしなければ分離することができない、
しかしながら、このことは、塔底圧力の上昇とそれにと
もなう温度上昇による熱変性という問題を引きおこし、
結局のところ、蒸留精製を著しく困難なものとする。
On the other hand, natural oils and fats containing eicosapentaenoic acids contain various fatty acids in addition to eicosapentaenoic acids, and since these have similar boiling points, they cannot be separated unless the height of the distillation column is made considerably high and the reflux amount is increased. can't do it,
However, this causes the problem of thermal denaturation due to an increase in bottom pressure and an accompanying rise in temperature.
Ultimately, it makes distillation purification extremely difficult.

このようなことから、従来方法では、蒸留による濃縮は
低レベルに抑え、後段の尿素付加処理等によって高度精
製することを余儀なくされていた。
For this reason, in conventional methods, concentration by distillation must be kept to a low level, and high-level purification must be carried out by subsequent urea addition treatment.

また、後段プロセスの負荷は極めて大きなものにならざ
るを得なかった。
In addition, the load on subsequent processes inevitably becomes extremely heavy.

しかしながら、この発明の方法によって、このような問
題の発生もなく、蒸留精製のみによって、簡便な操作で
、しかも高効率に80%以上、さらには85%以上の濃
度の高純度エイコサペンタエン酸またはそのエステルの
取得を可能とするため、その後の尿素付加処理によって
、極めて高効率に、かつ高濃度品への精製が可能となる
However, with the method of the present invention, such problems do not occur, and highly purified eicosapentaenoic acid or its eicosapentaenoic acid with a concentration of 80% or more, or even 85% or more, can be produced with simple operation and high efficiency by only distillation purification. Since the ester can be obtained, the subsequent urea addition treatment makes it possible to purify the product with extremely high efficiency and high concentration.

この発明の方法が対象とする脂肪酸混合物は、エイコサ
ペンタエン酸またはそのグリセリド等の誘導体を多く含
有する天然油脂から得られる任意のものを用いることが
でき、たとえば、イワシ、サバ、ニシン、サンマ等の魚
、ナンキョクオキアミ、ツノナシオキアミ、コベボーダ
等の動物性海洋プランクトン等の適宜なものから得られ
る脂肪酸混合物を使用することができる。
The fatty acid mixture targeted by the method of the present invention can be any one obtained from natural fats and oils containing a large amount of eicosapentaenoic acid or its derivatives such as glycerides, such as sardines, mackerel, herring, saury, etc. Fatty acid mixtures obtained from suitable sources such as fish, Antarctic krill, Antarctic krill, and zooplankton such as Kobeboda can be used.

これらの脂肪酸混合物は、所望により、エステル化して
連続蒸留する。
These fatty acid mixtures are optionally esterified and continuously distilled.

この発明の連続蒸留法においては、充填式、スプリング
式、棚段式等の各種の方式のものが採用でき、より好ま
しくは、網目板状体を用い、理論段数5以上とすること
ができる。
In the continuous distillation method of the present invention, various methods such as a packed type, a spring type, and a tray type can be employed, and more preferably, a mesh plate-like body is used and the number of theoretical plates is 5 or more.

3塔以上の蒸留塔からなるこの発明の方法での連続蒸留
は、いずれも、10 Torr以下、より好ましくは、
0. ITorr前後の減圧条件、および210℃以下
、より好ましくは、195℃以下の塔底温度において実
施する。
The continuous distillation in the method of the present invention, which consists of three or more distillation columns, is performed at a pressure of 10 Torr or less, more preferably,
0. It is carried out under reduced pressure conditions around ITorr and at a bottom temperature of 210°C or lower, more preferably 195°C or lower.

この3塔以上の蒸留塔の構成は、いずれの場合も、その
うちの1塔は初留分回収のための精留塔として独立させ
る。たとえば3塔によって構成する場合には、 (I)  第1蒸留塔 (II)  第2蒸留塔(初留分精留塔)(1)  第
3蒸留塔(主留分および後留分精留塔) に区分し、また4塔によって構成する場合には、(I>
  第1蒸留塔 (It>  第2蒸留塔(初留分精留塔)(I)  第
3蒸留塔(後留分分離) (TV)  第4蒸留塔(主留分精留塔)に区分する。
In any case, in this configuration of three or more distillation columns, one of the columns is made independent as a rectification column for recovering the initial fraction. For example, in the case of three columns, (I) first distillation column (II) second distillation column (first distillation column) (1) third distillation column (main distillation column and rear distillation column) ), and when it is composed of four towers, (I>
1st distillation column (It> 2nd distillation column (first distillation column) (I) 3rd distillation column (last distillation separation) (TV) 4th distillation column (main distillation column) .

さらに、3塔の場合には、(I)  第1蒸留塔(初留
分精留塔)(It)  第2蒸留塔(後留分精留塔)(
■) 第3蒸留塔(主留分精留塔) に区分することもできる。もちろん、精留塔の構成をさ
らに細分化することもできる。
Furthermore, in the case of three columns, (I) the first distillation column (first distillation column) (It) the second distillation column (second distillation column) (
■) It can also be divided into a third distillation column (main fraction rectification column). Of course, the configuration of the rectification column can also be further subdivided.

いずれの場合にも、この発明の方法においては、初留分
精留塔の塔底液は前段の、すなわち上記の構成例では第
1蒸留塔への還流液として戻すことを必須としている。
In any case, in the method of the present invention, it is essential that the bottom liquid of the initial fraction rectification column is returned as a reflux liquid to the previous stage, that is, the first distillation column in the above configuration example.

また、第1蒸留塔の塔頂留分をいったん凝縮させた後に
、凝縮液の状態で初留分精留塔に送ることも好ましい態
様としている。
Further, it is also a preferred embodiment that the top fraction of the first distillation column is once condensed and then sent in the form of a condensate to the first fraction rectification column.

さらに、各々の蒸留塔は、その真空度や塔底温度を厳密
に制御することが必要であることから、各塔毎に独立し
た真空系を設けることが好ましい。
Furthermore, since it is necessary to strictly control the degree of vacuum and bottom temperature of each distillation column, it is preferable to provide an independent vacuum system for each column.

連続蒸留により得られるC2゜の主留分、すなわち、エ
イコサペンタエン酸またはそのエステルを含有する主留
分は、次いで尿素処理し、尿素付加体を生成させる。こ
の時、尿素をメタノール、エタノール等の高溶解性の溶
媒に溶解して尿素溶液として使用する8通常、尿素濃度
5〜20%程度とする。
The C2° main fraction obtained by continuous distillation, ie, the main fraction containing eicosapentaenoic acid or its ester, is then treated with urea to produce a urea adduct. At this time, urea is used as a urea solution by dissolving it in a highly soluble solvent such as methanol or ethanol.8Usually, the urea concentration is about 5 to 20%.

主留分とこの尿素溶液との混合は、主留分1重量部に対
して、0.5〜10部程度の割合で行い、室温以下、よ
り好ましくは15℃以下にまで強制冷却する。このよう
な処理によって、主留分中の低不飽和度、たとえば1〜
4個の不飽和結合を有するC2o脂肪酸類を尿素との複
合体として析出させて分離することができる。
The main fraction and this urea solution are mixed at a ratio of about 0.5 to 10 parts per 1 part by weight of the main fraction, and the mixture is forcibly cooled to below room temperature, preferably below 15°C. By such treatment, the degree of unsaturation in the main fraction is low, e.g.
C2o fatty acids having four unsaturated bonds can be precipitated and separated as a complex with urea.

次いでこの発明の方法においては、反応混合物に、非極
性溶剤、たとえばヘキサン、イソオクタン等を加え、尿
素付加体および残存する尿素をメタノール層等に、脂肪
酸類はヘキサン層等に移行させて抽出分離する。
Next, in the method of this invention, a nonpolar solvent such as hexane, isooctane, etc. is added to the reaction mixture, and the urea adduct and remaining urea are transferred to a methanol layer, etc., and fatty acids are transferred to a hexane layer, etc., for extraction and separation. .

次いで、必要に応じて色素、酸化物等の不純物を除去す
るため、吸着カラムを介して吸着処理する。
Next, in order to remove impurities such as dyes and oxides, adsorption treatment is performed via an adsorption column as required.

この時の吸着カラムとしては、シリカゲル、活性白土、
アルミナ、活性炭素等を用いることができるが、特にシ
リカゲルを好ましいものとして例示することができる。
The adsorption column used at this time is silica gel, activated clay,
Although alumina, activated carbon, etc. can be used, silica gel is particularly preferred.

その後、上記の溶媒を留去する。Thereafter, the above solvent is distilled off.

以下、添付した図面に沿ってこの発明の方法についてさ
らに詳しく説明する。
Hereinafter, the method of the present invention will be explained in more detail with reference to the accompanying drawings.

第1図は、4塔の蒸留塔を用いる例を示したものである
FIG. 1 shows an example using four distillation columns.

たとえばこの第1図に示したように、脂肪酸混合物(A
)を対象として、4塔の蒸留塔(1)(2)(3)(4
)を用いて連続蒸留する。
For example, as shown in Figure 1, a fatty acid mixture (A
), four distillation columns (1) (2) (3) (4
) for continuous distillation.

各々の蒸留塔(1)(2)(3)(4)には、独立して
、真空系(5)(6)(7)(8)および凝縮系(9)
(10)(11)(12)、さらに、リボイラー(13
)<14)(15)(16)を配設してもいる。
Each distillation column (1) (2) (3) (4) is independently equipped with a vacuum system (5) (6) (7) (8) and a condensation system (9).
(10) (11) (12), and reboiler (13)
)<14)(15)(16) are also provided.

この蒸留塔(1)(2)(3)(4)は、各々、10T
orr以下の減圧、および210℃以下の塔底温度に厳
密に制御する。真空度と温度とは密接な関係にあり、こ
の制御のために真空系(5)(6)(7)(8)を各々
独立にすることが好ましいが、このことは必ずしも必須
ではない、真空ポンプの能力や制御システム等に応じて
この真空系を適宜に構成してもよい。
The distillation columns (1), (2), (3), and (4) are each 10T.
The vacuum is strictly controlled below orr and the bottom temperature is below 210°C. The degree of vacuum and temperature are closely related, and for this control it is preferable to make the vacuum systems (5), (6), (7), and (8) independent, but this is not necessarily necessary. This vacuum system may be configured as appropriate depending on the capacity of the pump, the control system, etc.

以上の構成においては、まず原料(A)を第1蒸留塔(
1)に、たとえばその塔頂近傍に導入し、塔頂留分は凝
縮系(9)において凝縮し、第2蒸留塔(2)としての
初留分精留塔に、たとえばその塔底部に液状で導入する
。この液状での導入は、この発明の方法において重要な
ファクターのひとつである。
In the above configuration, first, the raw material (A) is transferred to the first distillation column (
1), for example near the top of the column, the top fraction is condensed in the condensation system (9), and the liquid is introduced into the first distillation column as the second distillation column (2), for example at the bottom of the column. will be introduced. Introduction in liquid form is one of the important factors in the method of this invention.

第2蒸留塔(2)においては、その塔頂留分としてより
低炭素数(<01゜)の脂肪酸類からなる初留分(B)
を回収する。また、その塔底液の一部は、第1蒸留塔(
1)の塔頂近傍に還流する。
In the second distillation column (2), the first distillate (B) consisting of fatty acids with a lower carbon number (<01°) is used as the top fraction.
Collect. In addition, a part of the bottom liquid is transferred to the first distillation column (
1) is refluxed near the top of the column.

これもこの発明の方法にとって極めて重要なファクター
である。第1蒸留塔(1)の塔底凝縮液もリボイラー(
13)で加熱して塔底部に戻すとともに、第3蒸留塔(
3)の塔頂近傍に、液状で導入する。
This is also a very important factor for the method of this invention. The bottom condensate of the first distillation column (1) is also reboiler (
13) and return it to the bottom of the column, and the third distillation column (
3) is introduced in liquid form near the top of the column.

この第3蒸留塔(3)の塔頂留分は凝縮系(11)を介
して凝縮液として第4蒸留塔(4)の塔底部に供給する
。また、塔底凝縮液は、リボイラー(15)によって加
熱して塔底部に戻すとともに、エイコサペンタエン酸ま
たはそのエステルより長鎖の021以上の脂肪酸から主
としてなる後留(残留)分(C)を回収する。
The top fraction of the third distillation column (3) is supplied to the bottom of the fourth distillation column (4) as a condensate through a condensation system (11). In addition, the bottom condensate is heated by the reboiler (15) and returned to the bottom of the tower, and the after-distillate (residual) fraction (C), which is mainly composed of fatty acids longer than 021 and longer than eicosapentaenoic acid or its ester, is recovered. do.

第3蒸留塔(3)の塔頂からの凝縮液を導入した第4蒸
留塔(4)においては、塔頂からの留分を凝縮系(12
)において凝縮し、一部を塔頂近傍に還流するとともに
、エイコサペンタエン酸またはそのエステルを主なもの
とする主留分(D)を回収する。一方、塔底凝縮液はり
ボイラー(16)で加熱して塔底に戻すとともに、一部
を、第3蒸留塔(3)の塔頂近傍に還流する。
In the fourth distillation column (4) into which the condensate from the top of the third distillation column (3) is introduced, the fraction from the top of the column is transferred to the condensate system (12
), a portion of which is refluxed near the top of the column, and a main fraction (D) containing eicosapentaenoic acid or its ester as a main fraction is recovered. On the other hand, the bottom condensate is heated in the boiler (16) and returned to the bottom of the column, and a portion is refluxed near the top of the third distillation column (3).

なお、原料(A)は、第1蒸留塔(1)への導入前に、
減圧に保ったフラッシュタンク(17)において処理し
、空気や水分等の不純物を除去するようにしてもよい。
In addition, before introducing the raw material (A) into the first distillation column (1),
The process may be performed in a flash tank (17) maintained at reduced pressure to remove impurities such as air and moisture.

また、リボイラー(13)(14)(15)(16)に
は、加熱時間を短くすることができる流下薄膜蒸発型の
ものを採用することが有利である。これにより、より効
果的に熱劣化を防ぐことができる。
Furthermore, it is advantageous to employ a falling film evaporation type reboiler (13), (14), (15), and (16) that can shorten the heating time. Thereby, thermal deterioration can be more effectively prevented.

第2図は、尿素付船体生成の処理工程を例示したもので
ある。上記の連続蒸留により得られるエイコサペンタエ
ン酸またはそのエステルの濃度が80%以上の主留分(
D)を処理する。
FIG. 2 illustrates the processing steps for producing a hull with urea. The main fraction with a concentration of eicosapentaenoic acid or its ester of 80% or more obtained by the above continuous distillation (
D).

第2図に例示したように、この主留分(D)は、尿素溶
液との接触塔(21)に送り、たとえば尿素メタノール
溶液をタンク(22)より導いて接触させる。この時、
尿素メタノール溶液は、35〜45℃程度の温度で導入
し、接触塔(21)において室温以下になるように強制
冷却する。
As illustrated in FIG. 2, this main fraction (D) is sent to a contact column (21) with a urea solution, and is brought into contact with, for example, a urea methanol solution introduced from a tank (22). At this time,
The urea methanol solution is introduced at a temperature of about 35 to 45°C, and is forcedly cooled to below room temperature in the contact tower (21).

次いで処理液は、タンク(23)を介して非極性溶媒、
たとえばn−ヘキサンを用いての製品抽出塔(24)に
送る。尿素メタノール溶液および尿素付加体を分離した
製品溶剤層(E)は、次の処理工程に送る。尿素メタノ
ール溶液および尿素付加体は、タンク(25)に送り、
尿素付加体を熱分解したのち、残渣抽出塔(25’ )
において再度抽出処理をし、残渣溶剤層(G)を分離す
る。
Next, the treatment liquid is passed through a tank (23) to a non-polar solvent,
The product is sent to a product extraction column (24), for example using n-hexane. The product solvent layer (E) from which the urea methanol solution and the urea adduct have been separated is sent to the next treatment step. The urea methanol solution and the urea adduct are sent to a tank (25),
After thermally decomposing the urea adduct, the residue extraction column (25')
The extraction process is carried out again in , and the residual solvent layer (G) is separated.

非極性溶媒は、冷却管(26)、あるいは加熱管(27
)において冷却あるいは加熱して、抽出塔(24)(2
5′)に送る。溶剤層(E)(G)は、デカンタ−(2
8)(29)より取出す。
The non-polar solvent is passed through the cooling tube (26) or the heating tube (27).
) in the extraction tower (24) (2
5'). The solvent layers (E) and (G) are placed in a decanter (2
8) Take out from (29).

次いで製品溶剤層(E)を、第3図に示したように、タ
ンク(31)を介してメタノール精留塔(32)に送る
。メタノール凝縮器(33)およびメタノール蒸発器(
34)を配置したこの精留塔(32)での操作によって
、脱メタノール処理した製品抽出溶剤層が得られ、これ
を枦遇することにより残存する尿素を除去する。
The product solvent layer (E) is then sent to a methanol rectification column (32) via a tank (31), as shown in FIG. Methanol condenser (33) and methanol evaporator (
By operating this rectification column (32) equipped with 34), a demethanol-treated product extraction solvent layer is obtained, and by handling this, residual urea is removed.

次いで、これをタンク(35)を介して吸着カラム(3
6)(37)に導き、色素や酸化物等の不純物を除去し
、続いて、蒸発器(38)において溶媒、たとえばn−
ヘキサンを除去する。
Next, this is passed through a tank (35) to an adsorption column (3).
6) (37) to remove impurities such as dyes and oxides, and then in an evaporator (38) to remove a solvent such as n-
Remove hexane.

この蒸発器(38)には、n−ヘキサン凝縮器(39)
を配置する。
This evaporator (38) is equipped with an n-hexane condenser (39).
Place.

このようにして製品(F)が得られる。製品(F)の最
終濃度は85%以上にまで上昇する。
Product (F) is thus obtained. The final concentration of product (F) increases to more than 85%.

次にこの第1図から第3図に例示した装置を用いてのこ
の発明の製造方法の具体的な製造例を示す。
Next, a specific manufacturing example of the manufacturing method of the present invention using the apparatus illustrated in FIGS. 1 to 3 will be shown.

く製造例1〉 魚油から得られた脂肪酸(c19以下60%、C2o2
3%、021以上17%)混合物のエチルエステルを、
I TOrrの真空に保ったフラッシュタンク(17)
にて処理し、次いで、塔径300 mr、高さ約7mで
、0.1Torrの真空に保った第1蒸留塔(1)に1
5〜20j/hrの割合で供給した。
Production Example 1> Fatty acid obtained from fish oil (60% below C19, C2o2
3%, 021 or more 17%) ethyl ester of the mixture,
Flash tank (17) maintained at a vacuum of I Torr
The first distillation column (1), which has a column diameter of 300 mr, a height of about 7 m, and is maintained at a vacuum of 0.1 Torr,
It was supplied at a rate of 5 to 20j/hr.

この第1蒸留塔(1)においては、塔底温度194〜1
95℃、塔頂温度124〜125℃となるようにした。
In this first distillation column (1), the column bottom temperature is 194 to 1
The temperature at the top of the column was set at 95°C and 124-125°C.

また、その内部には、4圓網目の網目状板を装置し、そ
の理論段数は4段とした。この第1蒸留塔(1)には、
その塔底に02゜以上の脂肪酸エステル混合物が集まる
ことがら、この−第1蒸留塔の塔底部の真空度および温
度の制御が難しくなる。このため、第1蒸留塔内への充
填物の量は第2蒸留塔(2)よりも少なくした。
Moreover, a mesh plate with a four-ring mesh was installed inside, and the number of theoretical plates was set to four. In this first distillation column (1),
Since the fatty acid ester mixture with a temperature of 0.2° or more gathers at the bottom of the column, it becomes difficult to control the degree of vacuum and temperature at the bottom of the first distillation column. For this reason, the amount of packing material in the first distillation column was smaller than that in the second distillation column (2).

第1蒸留塔(1)の塔頂凝縮液は、第2蒸留塔(2)の
塔底部に導入した。この第2塔の塔底温度は184〜1
85℃、塔頂温度はiio〜111℃となるようにし、
0. ITorrの減圧において操作した。
The top condensate of the first distillation column (1) was introduced into the bottom of the second distillation column (2). The bottom temperature of this second column is 184-1
85°C, the tower top temperature should be between io and 111°C,
0. It was operated at a vacuum of ITorr.

理論段数は6段とした。また、塔頂留分は、還流比1:
2で還流し、一部は、初留分(B)として回収した。
The number of theoretical plates was 6. In addition, the top fraction has a reflux ratio of 1:
2 and a portion was recovered as the first distillate (B).

この初留分の組成は、表1にも示したように、C1,以
下の脂肪酸類99%、C2o工イコサペンタエン酸エス
テル他1%、021以上の脂肪酸類O%であった。
As shown in Table 1, the composition of this initial distillate was 99% fatty acids of C1 and below, 1% of C2o modified icosapentaenoic acid ester and others, and 0% of fatty acids of 021 and above.

第2蒸留塔(2)については、その塔底液が液面として
一定になるように制御し、第1蒸留塔(1)の塔頂近傍
に戻した。つまり、この塔底凝縮液は還流液として第1
蒸留塔(1)に戻した。
Regarding the second distillation column (2), the bottom liquid was controlled to have a constant liquid level and returned to the vicinity of the top of the first distillation column (1). In other words, this tower bottom condensate is used as the reflux liquid.
It was returned to the distillation column (1).

第1蒸留塔(1)の塔底液は、第3蒸留塔(3)の塔頂
近傍に供給した。この第3蒸溜塔(3)の圧力は0.I
Torrの減圧条件とし、また塔底温度は194〜19
5℃、塔頂温度は124〜125℃となるようにした。
The bottom liquid of the first distillation column (1) was supplied to the vicinity of the top of the third distillation column (3). The pressure of this third distillation column (3) is 0. I
Torr reduced pressure conditions, and the bottom temperature was 194 to 19
5°C, and the tower top temperature was set at 124-125°C.

理論段数は4段とした。The number of theoretical plates was 4.

第3蒸留塔(3)の塔底液として、後留(残留)分(C
)を回収した。この後留の組成は、表1に示した通り、
019以下の脂肪酸類0.1%、C2o工イコサペンタ
エン酸エステル他20%、C21以上の脂肪酸類79.
9%であった。
As the bottom liquid of the third distillation column (3), the after-distillation (residual) fraction (C
) were collected. The composition of this residue is as shown in Table 1.
0.1% of fatty acids of 019 or less, 20% of C2o-engineered icosapentaenoic acid ester, fatty acids of C21 or more 79.
It was 9%.

この第3蒸留塔(3)の塔頂留分は、凝縮液として第4
蒸留塔(4)の塔底部に供給した。理論段数6段のこの
第4蒸留塔(4)は、0.1Torrの減圧で、塔底温
度194〜195℃、塔頂温度110〜111℃となる
ように操作した。
The top fraction of this third distillation column (3) is transferred to the fourth distillation column as a condensate.
It was supplied to the bottom of the distillation column (4). This fourth distillation column (4) having six theoretical plates was operated at a reduced pressure of 0.1 Torr so that the bottom temperature was 194 to 195°C and the top temperature was 110 to 111°C.

塔底液は、還流液として第3蒸留塔(3)の塔頂部に戻
した。この時の、第4蒸留塔の塔底液面は一定となるよ
うにした。
The bottom liquid was returned to the top of the third distillation column (3) as a reflux liquid. At this time, the liquid level at the bottom of the fourth distillation column was kept constant.

塔頂凝縮液は、還流比1:2で還流させ、同時に主留分
(D)を回収した。
The top condensate was refluxed at a reflux ratio of 1:2, and the main fraction (D) was collected at the same time.

この主留分の組成は、表1に示したように、C以下の脂
肪酸類0.1%、021以上の脂肪酸類0%、C2oエ
イコサペンタエン酸エステル他99.9%であった。
As shown in Table 1, the composition of this main fraction was 0.1% of C or lower fatty acids, 0% of 021 or higher fatty acids, and 99.9% of C2o eicosapentaenoic acid ester and others.

C2o留分のうちのエイコサペンタエン酸エチルエステ
ルの濃度は88%であった。
The concentration of eicosapentaenoic acid ethyl ester in the C2o fraction was 88%.

く比較例〉 比較のために、第4図に示した2塔の構成からなる蒸留
塔(41)(42)(理論段数10段)による連続減圧
蒸留を試みた。
Comparative Example> For comparison, continuous vacuum distillation was attempted using the two-column distillation columns (41) and (42) (10 theoretical plates) shown in FIG.

この時も、各々の蒸留塔(41>(42)には、独立の
真空系(43)(44)および凝縮系(45)(46)
を設け、リボリラー(47)(48)も配置した。
At this time, each distillation column (41>(42) has an independent vacuum system (43) (44) and a condensing system (45) (46).
were installed, and Riborillar (47) and (48) were also placed.

第1蒸留塔(41)塔頂より初留分(B′)を、第2蒸
留塔(42)塔頂より主留分(D′)、またその塔底よ
り後留(残留)分(C゛)を回収するようにした。各々
の蒸留塔(41)(42)は0、ITOrrの減圧条件
とした。第1蒸留塔(41)の塔底温度を195℃以下
となるように試みたが、温度制御は困難で210℃以上
になる場合があった。
The first distillate (B') is passed through the top of the first distillation column (41), the main distillate (D') is passed through the top of the second distillation column (42), and the rear distillate (residual) fraction (C) is passed through the bottom of the column (42).゛). Each distillation column (41) (42) was set to a reduced pressure condition of 0 and ITOrr. Although attempts were made to keep the bottom temperature of the first distillation column (41) below 195°C, temperature control was difficult and the temperature sometimes reached 210°C or above.

初留分、主留分および後留分の組成は表2に示した通り
であり、C2゜留分の分離精製効率はこの発明の方法に
比べてはるかに劣り、また、蒸留操作の制御は著しく困
難となった。また、C2o留分として回収された主留分
のうちのエイコサペンタエン酸エチルエステルは76%
にとどまった。第1蒸留塔(41)の塔底温度を195
°C以下に制御しても、この表2がら明らかなように、
どうしても、より低炭素数の、特にC18脂肪酸類の混
入が避けられず、製品としては全く不充分なものとなっ
た。
The compositions of the first distillate, main fraction, and rear distillate are shown in Table 2, and the separation and purification efficiency of the C2° fraction is far inferior to that of the method of this invention, and the control of the distillation operation is difficult. It became extremely difficult. In addition, eicosapentaenoic acid ethyl ester of the main fraction recovered as C2o fraction was 76%.
I stayed there. The bottom temperature of the first distillation column (41) is set to 195
Even if the temperature is controlled below °C, as is clear from Table 2,
However, the contamination of fatty acids with a lower carbon number, especially C18, was unavoidable, resulting in a completely unsatisfactory product.

表  1 表  2 く製造例2〉 製造例1から得られたC2o工チルエステル濃度99.
9%、エイコサペンタエン酸エチルエステル濃度88%
の主留分(D)を、接触塔(21)において、15%尿
素メタノーム溶液と接触させた。
Table 1 Table 2 Production Example 2> C2o-engineered methyl ester concentration obtained from Production Example 1: 99.
9%, eicosapentaenoic acid ethyl ester concentration 88%
The main fraction (D) was contacted with a 15% urea methanome solution in the contact column (21).

この溶液の温度は42℃とし、また接触塔(21)にお
いては、10℃まで強制冷却した 10℃に冷却したn−ヘキサンを用い抽出塔(24)に
おいて抽出処理した。
The temperature of this solution was 42°C, and the contact tower (21) was forcibly cooled to 10°C, and the solution was extracted using n-hexane cooled to 10°C in the extraction tower (24).

得られた製品溶剤層(E)は、メタノール精留塔(32
)においてメタノール除去し、さらに尿素を枦別した。
The obtained product solvent layer (E) is passed through a methanol rectification column (32
), methanol was removed, and urea was further separated.

製品溶剤層(E)には、脂肪酸エステル   12〜1
3% メタノール         5% ヘキサン      82〜83% 微量の尿素 が含まれていたが、このうちのメタノールと尿素が完全
に除去された。
The product solvent layer (E) contains fatty acid ester 12-1
3% methanol 5% hexane 82-83% Although a trace amount of urea was contained, methanol and urea were completely removed.

処理液は、次いで、シリカゲルの吸着カラム(36)(
37)に導き、色素や酸化物等の不純物を除去し、さら
に蒸発器(38)においてヘキサンを留去して、エイコ
サペンタエン酸エチルエステル製品(F)を得た。この
ものの濃度は93%であった。
The treated solution is then passed through a silica gel adsorption column (36) (
37) to remove impurities such as dyes and oxides, and then distill off hexane in an evaporator (38) to obtain an eicosapentaenoic acid ethyl ester product (F). The concentration of this product was 93%.

(発明の効果) 以上詳しく説明した通り、この発明の方法によって、8
5%以上、さらには90%以上の濃度(純度)を有する
エイコサペンタエン酸またはそのエステルの取得が可能
となる。しかも高効率での製造が実現される。
(Effect of the invention) As explained in detail above, by the method of this invention, 8
It becomes possible to obtain eicosapentaenoic acid or its ester having a concentration (purity) of 5% or more, and even 90% or more. Moreover, highly efficient manufacturing is realized.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、この発明の方法の一実施例を示した装置構成
模式図である。第2図は、従来の2塔方式の例を示した
模式図である。 1.2,3.4・・・蒸留塔 5.6,7.8・・・真空系 9.10,11.12・・・凝縮系 13.14,15.16・・・リボイラー21・・・接
  触  塔 22・・・タ  ン  り 23・・・タンク 24・・・製品抽出塔 25・・・タンク 25′・・・残渣抽出塔 26・・・冷 却 管 27・・・加 熱 管 28.29・・・デカンタ− 31・・・タ  ン り 32・・・メタノール精留塔 33・・・メタノール蒸発器 34・・・メタノール蒸発器 35・・・タ  ン り 36.37・・・吸着カラム 38・・・蒸 発 器 39・・・ヘキサン11!縮器 A・・・原   料 B・・・初留分 C・・・後留(残留)分 D・・・主 留 分 E・・・製品溶剤層 F・・・製 品 G・・・残液溶剤層
FIG. 1 is a schematic diagram of an apparatus configuration showing an embodiment of the method of the present invention. FIG. 2 is a schematic diagram showing an example of a conventional two-column system. 1.2, 3.4... Distillation column 5.6, 7.8... Vacuum system 9.10, 11.12... Condensation system 13.14, 15.16... Reboiler 21...・Contact tower 22...Tank 23...Tank 24...Product extraction tower 25...Tank 25'...Residue extraction tower 26...Cooling pipe 27...Heating pipe 28.29... Decanter 31... Tank 32... Methanol rectification column 33... Methanol evaporator 34... Methanol evaporator 35... Tank 36.37... Adsorption column 38...evaporator 39...hexane 11! Condenser A...Raw material B...First distillate C...Following distillate (residual) fraction D...Main distillate E...Product solvent layer F...Product G...Residual liquid solvent layer

Claims (7)

【特許請求の範囲】[Claims] (1)エイコサペンタエン酸またはその誘導体を含む天
然油脂から得られる脂肪酸またはそのエステルの混合物
を、低炭素数脂肪酸類初留分の精留塔を独立させた3塔
以上の蒸留塔において、この精留塔塔底液を前段蒸留塔
に還流し、10Torr以下の減圧および210℃以下
の塔底温度において連続蒸留し、得られたエイコサペン
タエン酸またはそのエステルを主成分として含有する主
留分を尿素溶液と接触させて尿素付加体を生成させ、非
極性溶媒を用いて抽出処理し、次いで溶媒を留去して、
濃度85%以上のエイコサペンタエン酸またはそのエス
テルを得ることを特徴とするエイコサペンタエン酸また
はそのエステルの製造方法。
(1) A mixture of fatty acids or esters thereof obtained from natural fats and oils containing eicosapentaenoic acid or its derivatives is purified in three or more distillation columns each having an independent rectification column for the initial fraction of low carbon number fatty acids. The bottom liquid of the distillation column is refluxed to the first stage distillation column and continuously distilled at a reduced pressure of 10 Torr or less and a bottom temperature of 210°C or less, and the main fraction containing eicosapentaenoic acid or its ester as a main component is converted into urea. Contacting with a solution to produce a urea adduct, extraction using a non-polar solvent, and then distilling off the solvent,
A method for producing eicosapentaenoic acid or an ester thereof, characterized by obtaining eicosapentaenoic acid or an ester thereof having a concentration of 85% or more.
(2)塔頂留分の凝縮液を初留分精留塔に送る請求項(
1)記載のエイコサペンタエン酸またはそのエステルの
製造方法。
(2) A claim for sending the condensate of the overhead fraction to the first distillation column
1) The method for producing eicosapentaenoic acid or its ester.
(3)初留分精留塔の塔底液を前段蒸留塔塔頂近傍に還
流する請求項(1)または(2)記載のエイコサペンタ
エン酸またはそのエステルの製造方法。
(3) The method for producing eicosapentaenoic acid or its ester according to claim (1) or (2), wherein the bottom liquid of the initial fraction rectification column is refluxed to the vicinity of the top of the first distillation column.
(4)エイコサペンタエン酸またはそのエステルを主成
分として含有する主留分精留塔と、高炭素数脂肪酸類後
留分の精留塔とを各々独立させて連続蒸留する請求項(
1)、(2)または(3)記載のエイコサペンタエン酸
またはそのエステルの製造方法。
(4) A claim in which a main fraction rectification column containing eicosapentaenoic acid or its ester as a main component and a rectification column for a high carbon number fatty acid post-fraction are separated and continuously distilled (
The method for producing eicosapentaenoic acid or its ester according to 1), (2) or (3).
(5)各々の蒸留塔が独立した真空系および凝縮系を有
する請求項(1)、(2)、(3)または(4)記載の
エイコサペンタエン酸またはそのエステルの製造方法。
(5) The method for producing eicosapentaenoic acid or its ester according to claim (1), (2), (3) or (4), wherein each distillation column has an independent vacuum system and a condensation system.
(6)室温以下の温度において尿素メタノール溶液と主
留分とを接触させる請求項(1)、(2)、(3)、(
4)または(5)記載のエイコサペンタエン酸またはそ
のエステルの製造方法。
(6) Claims (1), (2), (3), (
4) or the method for producing eicosapentaenoic acid or its ester according to (5).
(7)非極性溶媒がヘキサンである請求項(1)、(2
)、(3)、(4)、(5)または(6)記載のエイコ
サペンタエン酸またはそのエステルの製造方法。
(7) Claims (1) and (2) wherein the nonpolar solvent is hexane.
), (3), (4), (5) or (6), the method for producing eicosapentaenoic acid or its ester.
JP2145617A 1990-06-04 1990-06-04 Method for producing eicosapentaenoic acid or ester thereof Expired - Lifetime JP3040136B2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP2145617A JP3040136B2 (en) 1990-06-04 1990-06-04 Method for producing eicosapentaenoic acid or ester thereof
CA002043615A CA2043615C (en) 1990-06-04 1991-06-03 Method of producing eicosapentaenoic acid or the ester derivative thereof
AU78186/91A AU641016B2 (en) 1990-06-04 1991-06-04 Method of producing eicosapentaenoic acid or the ester derivatives thereof
AT91305044T ATE147062T1 (en) 1990-06-04 1991-06-04 METHOD FOR PRODUCING EICOSAPENTAENIC ACID OR AN ESTER DERIVATIVE THEREOF
NO912144A NO177699C (en) 1990-06-04 1991-06-04 Process and apparatus for preparing eicosapentaenoic acid or its ester derivative
KR1019910009345A KR100208701B1 (en) 1990-06-04 1991-06-04 Method of producing eicosapentaenoic acid or an ester derivative thereof
DE69123880T DE69123880T2 (en) 1990-06-04 1991-06-04 Process for the preparation of eicosapentaenoic acid or an ester derivative thereof
ES91305044T ES2095909T3 (en) 1990-06-04 1991-06-04 METHOD FOR PRODUCING EICOSAPENTAENOIC ACID OR AN ESTER DERIVED FROM IT.
DK91305044.9T DK0460917T3 (en) 1990-06-04 1991-06-04 Process for preparing eicosapentaenoic acid or an ester derivative thereof
EP91305044A EP0460917B1 (en) 1990-06-04 1991-06-04 Method of producing eicosapentaenoic acid or an ester derivative thereof
GR970400347T GR3022660T3 (en) 1990-06-04 1997-02-26 Method of producing eicosapentaenoic acid or an ester derivative thereof
JP10354409A JPH11236591A (en) 1990-06-04 1998-12-14 Preparation of highly pure eicosapentaenoic acid or its ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2145617A JP3040136B2 (en) 1990-06-04 1990-06-04 Method for producing eicosapentaenoic acid or ester thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP35441198A Division JPH11246888A (en) 1998-12-14 1998-12-14 Production of highly pure eicosapentaenoic acid or its ester
JP10354409A Division JPH11236591A (en) 1990-06-04 1998-12-14 Preparation of highly pure eicosapentaenoic acid or its ester

Publications (2)

Publication Number Publication Date
JPH0441457A true JPH0441457A (en) 1992-02-12
JP3040136B2 JP3040136B2 (en) 2000-05-08

Family

ID=15389173

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2145617A Expired - Lifetime JP3040136B2 (en) 1990-06-04 1990-06-04 Method for producing eicosapentaenoic acid or ester thereof

Country Status (1)

Country Link
JP (1) JP3040136B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07278585A (en) * 1994-04-06 1995-10-24 Nippon Kagaku Shiryo Kk Method for purifying eicosapentaenoic acid or its ester
JPH1149723A (en) * 1997-08-08 1999-02-23 Shin Etsu Chem Co Ltd Purification of higher unsaturated aliphatic ester
JP2006502224A (en) * 2002-10-07 2006-01-19 クロンプトン コーポレーション Method for separating saturated fatty acids from fatty acid mixtures using polyglycerol esters as auxiliaries
JP2011522913A (en) * 2008-05-15 2011-08-04 プロノヴァ バイオファーマ ノルゲ アーエス Krill oil processing method
CN102417447A (en) * 2011-10-31 2012-04-18 广西亿康药业股份有限公司 Production method of undecylenic acid
WO2016043251A1 (en) * 2014-09-17 2016-03-24 日本水産株式会社 Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
US11330817B2 (en) 2013-12-04 2022-05-17 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
EP4049537A1 (en) 2018-12-12 2022-08-31 Nippon Suisan Kaisha, Ltd. A composition containing highly unsaturated fatty acid or alkyl ester thereof and a method for producing the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5318011B1 (en) * 1967-01-12 1978-06-13
JPS5511660B2 (en) * 1976-05-28 1980-03-26
JPS57149400A (en) * 1981-03-12 1982-09-14 Kureha Chemical Ind Co Ltd Manufacture of high purity long chain highly unsaturated fatty acid ester
JPS57187397A (en) * 1981-05-15 1982-11-18 Nippon Suisan Kaisha Ltd Manufacture of eicosapentaenoic acid or ester of same
JPS588037A (en) * 1981-07-03 1983-01-18 Nippon Suisan Kaisha Ltd Preparation of eicosapentaenoic acid or its ester
JPS6448898A (en) * 1987-08-20 1989-02-23 Nisshin Flour Milling Co Production of eicosapentaenoic acid or ester thereof and docosahexaenoic acid or ester thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5318011B1 (en) * 1967-01-12 1978-06-13
JPS5511660B2 (en) * 1976-05-28 1980-03-26
JPS57149400A (en) * 1981-03-12 1982-09-14 Kureha Chemical Ind Co Ltd Manufacture of high purity long chain highly unsaturated fatty acid ester
JPS57187397A (en) * 1981-05-15 1982-11-18 Nippon Suisan Kaisha Ltd Manufacture of eicosapentaenoic acid or ester of same
JPS588037A (en) * 1981-07-03 1983-01-18 Nippon Suisan Kaisha Ltd Preparation of eicosapentaenoic acid or its ester
JPS6448898A (en) * 1987-08-20 1989-02-23 Nisshin Flour Milling Co Production of eicosapentaenoic acid or ester thereof and docosahexaenoic acid or ester thereof

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07278585A (en) * 1994-04-06 1995-10-24 Nippon Kagaku Shiryo Kk Method for purifying eicosapentaenoic acid or its ester
JPH1149723A (en) * 1997-08-08 1999-02-23 Shin Etsu Chem Co Ltd Purification of higher unsaturated aliphatic ester
JP2006502224A (en) * 2002-10-07 2006-01-19 クロンプトン コーポレーション Method for separating saturated fatty acids from fatty acid mixtures using polyglycerol esters as auxiliaries
JP2011522913A (en) * 2008-05-15 2011-08-04 プロノヴァ バイオファーマ ノルゲ アーエス Krill oil processing method
US8829215B2 (en) 2008-05-15 2014-09-09 Pronova Biopharma Norge As Krill oil process
CN102417447A (en) * 2011-10-31 2012-04-18 广西亿康药业股份有限公司 Production method of undecylenic acid
US11856952B2 (en) 2013-12-04 2024-01-02 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
US11330817B2 (en) 2013-12-04 2022-05-17 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
JPWO2016043251A1 (en) * 2014-09-17 2017-08-17 日本水産株式会社 Composition containing eicosapentaenoic acid alkyl ester and method for producing the same
US9918953B2 (en) 2014-09-17 2018-03-20 Nippon Suisan Kaisha, Ltd. Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
US10105340B2 (en) 2014-09-17 2018-10-23 Nippon Suisan Kaisha, Ltd. Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
US10576053B2 (en) 2014-09-17 2020-03-03 Nippon Suisan Kaisha, Ltd. Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
JP2020073667A (en) * 2014-09-17 2020-05-14 日本水産株式会社 Composition containing alkyl ester of eicosapentaenoic acid and method of producing the same
US10864185B2 (en) 2014-09-17 2020-12-15 Nippon Suisan Kaisha, Ltd. Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
JP2022008611A (en) * 2014-09-17 2022-01-13 日本水産株式会社 Eicosapentaenoic acid alkyl ester-containing composition and production method of the same
CN106795452A (en) * 2014-09-17 2017-05-31 日本水产株式会社 Composition and its manufacture method containing eicosapentaenoic acid alkyl ester
US11648229B2 (en) 2014-09-17 2023-05-16 Nippon Suisan Kaisha, Ltd. Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
WO2016043251A1 (en) * 2014-09-17 2016-03-24 日本水産株式会社 Composition containing eicosapentaenoic acid alkyl ester, and method for producing same
EP4049537A1 (en) 2018-12-12 2022-08-31 Nippon Suisan Kaisha, Ltd. A composition containing highly unsaturated fatty acid or alkyl ester thereof and a method for producing the same

Also Published As

Publication number Publication date
JP3040136B2 (en) 2000-05-08

Similar Documents

Publication Publication Date Title
JP3400466B2 (en) Method for producing high-purity eicosapentaenoic acid or ester thereof
JPH11236591A (en) Preparation of highly pure eicosapentaenoic acid or its ester
US5215630A (en) Method of purifying eicosapentaenoic acid or the ester derivative thereof by fractional distillation
US4377526A (en) Method of purifying eicosapentaenoic acid and its esters
JPS60109534A (en) Treatment of glycerol by distillation
JP2001213827A (en) Method for producing glycerol
US4595461A (en) Process for the non-degenerative distillation of fatty acids
JPH0441457A (en) Production of eicosapentaenoic acid or its ester
JP4024853B2 (en) Method for improving coloration and color stability of oleic acid
JP3614177B2 (en) Method for producing high-purity docosahexaenoic acid or its ester
JPH1095744A (en) Production of highly unsaturated aliphatic acid or its alkyl ester
JP3678317B2 (en) Method for concentrating eicosapentaenoic acid-containing material
JP3005638B2 (en) Method for producing high concentration eicosapentaenoic acid or ester thereof
JP2005290376A (en) Method for producing fatty acid having improved smell, color and heat stability
JPH11246888A (en) Production of highly pure eicosapentaenoic acid or its ester
JP3290152B2 (en) High concentration eicosapentaenoic acid or its ester
JP2988754B2 (en) High vacuum continuous distillation equipment
JPH09176678A (en) Method of concentration of fat or oil containing highly unsaturated aliphatic acid
JPH0525870B2 (en)
JPH10310551A (en) Purification of eicosapentaenoic acid or its ester
KR960013831B1 (en) Separation of monoalkyl maleate from dialkyl maleate
JPH11240850A (en) Production of eicosapentaenoic acid having high concentration or its ester
JPH07110956B2 (en) Process for producing eicosapentaenoic acid or its ester and docosahexaenoic acid or its ester
JPH01249742A (en) Concentration and fractionation apparatus of component of mixture of highly unsaturated fatty acid, its ester or such and method for concentration and fractionation of said component
JPH09263787A (en) Production of highly unsaturated fatty acid or alkyl ester thereof

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090303

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100303

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100303

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110303

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110303

Year of fee payment: 11